Mina C. Hosseinipour

Author

University of North Carolina at Chapel Hill ORCID

Also Known As

Aertker, Leela, Akiba, C.F., Alide, Noor, Amodan, Bob Omoda, Banda, Ndaziona P. K., Bisson, Gregory P, Bonongwe, Naomi, Bonumwezi, Jessica L., Boulware, David R, Brouwers, Pim

677

Publications

23.7K

Citations

H-Index

192

Concepts

All Affiliations

University of North Carolina at Chapel Hill University of Malawi Kamuzu Central Hospital Johns Hopkins University Ministry of Health

About

Mina C. Hosseinipour is an author at University of North Carolina at Chapel Hill specializing in medicine, hiv, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	55	3.3K
2	Nursing	9	9	251
3	Education	2	2	59
4	Arts	1	1	27
5	Health Sciences	1	1	115

Mina C. Hosseinipour

242

Publications

20.8K

Citations

H-Index

Page 1

	Year	Citations
Prevention of HIV-1 Infection with Early Antiretroviral Therapy Myron S. Cohen, Ying Qing Chen, Marybeth McCauley, New England Journal of Medicine	2011	6.9K
Antiretroviral Therapy for the Prevention of HIV-1 Transmission Myron S. Cohen, Ying Qing Chen, Marybeth McCauley, New England Journal of Medicine	2016	1.7K
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis Diane V. Havlir, Michelle A. Kendall, Prudence Ive, New England Journal of Medicine	2011	538
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial Beatriz Grinsztejn, Mina C. Hosseinipour, Heather J. Ribaudo, The Lancet Infectious Diseases Hptn 052Hiv/aids CounsellingTreatment And PreventionHuman RetrovirusAntiviral Therapy	2014	507
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial Sinéad Delany‐Moretlwe, James P. Hughes, Peter Bock, The Lancet Sexual HealthPhase 3Treatment And PreventionHuman RetrovirusAntiviral Therapy	2022	498
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa Síle F. Molloy, Cecilia Kanyama, Robert S. Heyderman, New England Journal of Medicine	2018	393
Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes Joseph N Jarvis, Tihana Bicanic, Angela Loyse, Clinical Infectious Diseases	2013	367
Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries Suzanna Awang Bono, Edlaine Faria de Moura Villela, Ching Sin Siau, Vaccines	2021	361
The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy Mina C. Hosseinipour, Joep JG van Oosterhout, Ralf Weigel, AIDS	2009	284
Gender and the Use of Antiretroviral Treatment in Resource-Constrained Settings: Findings from a Multicenter Collaboration Paula Braitstein, Andrew Boulle, Denis Nash, Journal of Women s Health	2008	195

Page 1